Full Text View
Tabular View
No Study Results Posted
Related Studies
Surveillance Study of Viral Infections Following Lung Transplantation
This study has been completed.
Study NCT00701922   Information provided by Hannover Medical School
First Received: June 17, 2008   Last Updated: December 31, 2008   History of Changes

June 17, 2008
December 31, 2008
October 2005
December 2007   (final data collection date for primary outcome measure)
Incidence of bronchiolitis obliterans syndrome [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00701922 on ClinicalTrials.gov Archive Site
  • Incidence of acute rejection [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Incidence of hospitalisation [ Time Frame: 1 year ] [ Designated as safety issue: No ]
  • Incidence of graft loss (death or re-do-transplantation) [ Time Frame: 2 year ] [ Designated as safety issue: No ]
Same as current
 
Surveillance Study of Viral Infections Following Lung Transplantation
Season Surveillance Study of Viral Infections in Lung Transplant Recipients

The present study was conducted to study the impact community acquired respiratory virus (CARV) infections in an outpatient setting on graft function of lung transplant recipients. The study was aimed to identify risk factors for CARV infections.

The study was further intended to investigate an association of Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human adenovirus (HAdV) with the development of BOS and to identify risk factors for virus detection in blood.

Informed consent was obtained from the LTx recipients and the study was approved of by the institutional review board of Hannover medical school.

LTx recipients are screened for CARV infections during the cold season (end October until end April) in a single-centre outpatient clinic. Symptoms of upper (URTI) and lower respiratory tract infections (URTI) are recorded by questionnaires and findings.

Nasopharyngeal and oropharyngeal swabs (NOS) were performed to detect RV-antigens by immunofluorescence testing (IFT) of respiratory-syncytial virus (RSV), adenovirus, parainfluenza (PIV), influenza and cultures for CARV are performed. BAL was performed when clinically indicated and processed by IFT. Multiplex-PCR to detect 14 CARV are processed in symptomatic patients.

In addition blood samples are monitored at each contact to investigate an association of Epstein-Barr virus (EBV), cytomegalovirus (CMV) and human adenovirus (HAdV) with the development of BOS and to identify risk factors for virus detection in blood.

 
Observational
Cohort, Prospective
  • Lung Transplantation
  • Bronchiolitis Obliterans
  • Epstein-Barr Virus Infections
  • Paramyxoviridae Infections
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
388
December 2007
December 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • adults 18-70 years
  • lung transplantation (including single, double, combination and re-do transplants)

Exclusion Criteria:

  • refused consent
Both
18 Years to 70 Years
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT00701922
Hannover Medical School, Hannover Medical School
4015
Hannover Medical School
  • Dpt. Pulmonology
  • Dpt. Virology
Principal Investigator: Jens T Gottlieb, MD Dpt. Pulmonary Medicine
Principal Investigator: Ilka Engelmann, MD Dpt. Virology, MHH
Hannover Medical School
December 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP